Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Genmab reported DKK2.42B in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
Agios Pharmaceuticals AGIO:US USD 96.22M 120.59M
Almirall SA ALM:SM EUR 427.56M 38.74M
Amgen AMGN:US USD 4.07B 538M
Artemis Alpha ATS:LN GBP 748K 85K
AstraZeneca AZN:LN USD 8.33B 1.78B
Bayer BAYN:GR EUR 11.42B 848M
BioMarin Pharmaceutical BMRN:US USD 537.07M 24.97M
Bluebird Bio BLUE:US USD -6056000 19.32M
Demant A/s WDH:DC DKK 8.59B 680M
Exelixis EXEL:US USD 379.96M 92.04M
Fresenius Medical Care FME:GR EUR 4.44B 201.87M
Galapagos GLPG:NA EUR 165.2M 79.76M
Genmab GEN:DC DKK 2.42B 145M
GlaxoSmithKline GSK:LN GBP 4.87B 640M
GN Store Nord GN:DC DKK 4.14B 688M
Hikma Pharmaceutical HIK:LN USD 1.24B 280M
Immunogen IMGN:US USD 92.26M 8.46M
Insmed INSM:US USD 213.37M 2.6M
Lonza Group LONN:SW CHF 2.35B 8M
Novartis NOVN:VX USD 10.35B 700M
Regeneron Pharmaceuticals REGN:US USD 2.22B 52.2M
Roche Holding ROG:VX 25.06B 4.31B
Seattle Genetics SGEN:US USD 704.23M 22.08M